A 3-year postdoctoral position is available in the Clinical Radiopharmacy Research Group led by Prof. Dr. Martin A. Walter at the University Hospital of Geneva, Switzerland. The preferable starting date is April 1st 2021. The position is part of a recently funded project to develop new methods for molecular imaging with positron emission tomography (PET).
The Clinical Radiopharmacy Research Group at the University Hospital of Geneva is a multidisciplinary team comprising chemists, radiochemists, biologists and physicians, committed to the development of novel approaches for disease detection and therapy, as well as their translation from bench to bed. The laboratories are located at the campus of the University Hospital of Geneva, and are equipped with the state-of-the-art facilities, including a core facility for small animal imaging. Successful candidates will join a stimulating research environment located in a clinical setting
We seek a talented and highly motivated candidate with a track record of animal experimentation and programming experience in Python and R. The ideal candidate is collaborative and creative, has a strong publication record, and is fluent in English. Practical experience with tools such as Biopython, and Scikit Learn, as well as previous experience on machine learning will be particularly useful for this position. The position is open to applicants with a PhD in biology, computational biology, bioinformatics, or related fields.
The application must include, a cover letter (statement of motivation, summarizing scientific work and research interest), a detailed CV with a list of publications, copies of educational certificates (academic transcripts only), and a list of 2-3 reference persons (name, institution, e-mail and phone number and relation to the candidate). The review of applications will begin immediately until the position is filled.
為防止簡歷投遞丟失請抄送一份至：boshijob@126.com（郵件標題格式：應聘職位名稱+姓名+學歷+專業+中國博士人才網）
中國-博士人才網發布
聲明提示：凡本網注明“來源：XXX”的文/圖等稿件，本網轉載出于傳遞更多信息及方便產業探討之目的，并不意味著本站贊同其觀點或證實其內容的真實性，文章內容僅供參考。
